26 research outputs found
Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole
A class of Ag(I) N-heterocyclic carbene silver complexes, 1–3, derived from 4,5-dichloro-1H-imidazole has been evaluated for their anticancer activity against the human cancer cell lines OVCAR-3 (ovarian), MB157 (breast), and Hela (cervical). Silver complexes 1–3 are active against the ovarian and breast cancer cell lines. A preliminary in vivo study shows 1 to be active against ovarian cancer in mice. The results obtained in these studies warrant further investigation of these compounds in vivo
The pipeline project:Pre-publication independent replications of a single laboratory's research pipeline
This crowdsourced project introduces a collaborative approach to improving the reproducibility of scientific research, in which findings are replicated in qualified independent laboratories before (rather than after) they are published. Our goal is to establish a non-adversarial replication process with highly informative final results. To illustrate the Pre-Publication Independent Replication (PPIR) approach, 25 research groups conducted replications of all ten moral judgment effects which the last author and his collaborators had "in the pipeline" as of August 2014. Six findings replicated according to all replication criteria, one finding replicated but with a significantly smaller effect size than the original, one finding replicated consistently in the original culture but not outside of it, and two findings failed to find support. In total, 40% of the original findings failed at least one major replication criterion. Potential ways to implement and incentivize pre-publication independent replication on a large scale are discussed. (C) 2015 The Authors. Published by Elsevier Inc.</p
Data from a pre-publication independent replication initiative examining ten moral judgement effects
We present the data from a crowdsourced project seeking to replicate findings in independent laboratories before (rather than after) they are published. In this Pre-Publication Independent Replication (PPIR) initiative, 25 research groups attempted to replicate 10 moral judgment effects from a single laboratory's research pipeline of unpublished findings. The 10 effects were investigated using online/lab surveys containing psychological manipulations (vignettes) followed by questionnaires. Results revealed a mix of reliable, unreliable, and culturally moderated findings. Unlike any previous replication project, this dataset includes the data from not only the replications but also from the original studies, creating a unique corpus that researchers can use to better understand reproducibility and irreproducibility in science
The pipeline project: Pre-publication independent replications of a single laboratory's research pipeline
This crowdsourced project introduces a collaborative approach to improving the reproducibility of scientific research, in which findings are replicated in qualified independent laboratories before (rather than after) they are published. Our goal is to establish a non-adversarial replication process with highly informative final results. To illustrate the Pre-Publication Independent Replication (PPIR) approach, 25 research groups conducted replications of all ten moral judgment effects which the last author and his collaborators had “in the pipeline” as of August 2014. Six findings replicated according to all replication criteria, one finding replicated but with a significantly smaller effect size than the original, one finding replicated consistently in the original culture but not outside of it, and two findings failed to find support. In total, 40% of the original findings failed at least one major replication criterion. Potential ways to implement and incentivize pre-publication independent replication on a large scale are discussed
Data from a pre-publication independent replication initiative examining ten moral judgement effects
We present the data from a crowdsourced project seeking to replicate findings in independent laboratories before (rather than after) they are published. In this Pre-Publication Independent Replication (PPIR) initiative, 25 research groups attempted to replicate 10 moral judgment effects from a single laboratory's research pipeline of unpublished findings. The 10 effects were investigated using online/lab surveys containing psychological manipulations (vignettes) followed by questionnaires. Results revealed a mix of reliable, unreliable, and culturally moderated findings. Unlike any previous replication project, this dataset includes the data from not only the replications but also from the original studies, creating a unique corpus that researchers can use to better understand reproducibility and irreproducibility in science.Link_to_subscribed_fulltex
The pipeline project: Pre-publication independent replications of a single laboratory's research pipeline
© 2015 The Authors This crowdsourced project introduces a collaborative approach to improving the reproducibility of scientific research, in which findings are replicated in qualified independent laboratories before (rather than after) they are published. Our goal is to establish a non-adversarial replication process with highly informative final results. To illustrate the Pre-Publication Independent Replication (PPIR) approach, 25 research groups conducted replications of all ten moral judgment effects which the last author and his collaborators had âin the pipelineâ as of August 2014. Six findings replicated according to all replication criteria, one finding replicated but with a significantly smaller effect size than the original, one finding replicated consistently in the original culture but not outside of it, and two findings failed to find support. In total, 40% of the original findings failed at least one major replication criterion. Potential ways to implement and incentivize pre-publication independent replication on a large scale are discussed.Link_to_subscribed_fulltex
The Interactions between l‑Tyrosine Based Nanoparticles Decorated with Folic Acid and Cervical Cancer Cells under Physiological Flow
Many anticancer drugs have been established clinically,
but their
efficacy can be compromised by nonspecific toxicity and an inability
to reach the desired cancerous intracellular spaces. In order to address
these issues, researchers have explored the use of folic acid as a
targeted moiety to increase specificity of chemotherapeutic drugs.
To expand upon such research, we have conjugated folic acid to functionalized
poly(ethylene glycol) and subsequently decorated the surface of l-tyrosine polyphosphate (LTP) nanoparticles. These nanoparticles
possess the appropriate size (100–500 nm) for internalization
as shown by scanning electron microscopy and dynamic light scattering.
Under simulated physiological flow, LTP nanoparticles decorated with
folic acid (targeted nanoparticles) show a 10-fold greater attachment
to HeLa, a cervical cancer cell line, compared to control nanoparticles
and to human dermal fibroblasts. The attachment of these targeted
nanoparticles progresses at a linear rate, and the strength of this
nanoparticle attachment is shown to withstand shear stresses of 3.0
dyn/cm<sup>2</sup>. These interactions of the targeted nanoparticles
to HeLa are likely a result of a receptor–ligand binding, as
a competition study with free folic acid inhibits the nanoparticle
attachment. Finally, the targeted nanoparticles encapsulated with
a silver based drug show increased efficacy in comparison to nondecorated
(plain) nanoparticles and drug alone against HeLa cells. Thus, targeted
nanoparticles are a promising delivery platform for developing anticancer
therapies that overexpress the folate receptors (FRs)
The Interactions between l‑Tyrosine Based Nanoparticles Decorated with Folic Acid and Cervical Cancer Cells under Physiological Flow
Many anticancer drugs have been established clinically,
but their
efficacy can be compromised by nonspecific toxicity and an inability
to reach the desired cancerous intracellular spaces. In order to address
these issues, researchers have explored the use of folic acid as a
targeted moiety to increase specificity of chemotherapeutic drugs.
To expand upon such research, we have conjugated folic acid to functionalized
poly(ethylene glycol) and subsequently decorated the surface of l-tyrosine polyphosphate (LTP) nanoparticles. These nanoparticles
possess the appropriate size (100–500 nm) for internalization
as shown by scanning electron microscopy and dynamic light scattering.
Under simulated physiological flow, LTP nanoparticles decorated with
folic acid (targeted nanoparticles) show a 10-fold greater attachment
to HeLa, a cervical cancer cell line, compared to control nanoparticles
and to human dermal fibroblasts. The attachment of these targeted
nanoparticles progresses at a linear rate, and the strength of this
nanoparticle attachment is shown to withstand shear stresses of 3.0
dyn/cm<sup>2</sup>. These interactions of the targeted nanoparticles
to HeLa are likely a result of a receptor–ligand binding, as
a competition study with free folic acid inhibits the nanoparticle
attachment. Finally, the targeted nanoparticles encapsulated with
a silver based drug show increased efficacy in comparison to nondecorated
(plain) nanoparticles and drug alone against HeLa cells. Thus, targeted
nanoparticles are a promising delivery platform for developing anticancer
therapies that overexpress the folate receptors (FRs)